Please assess the completion status of the following clinical trial:

Trial Title: Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Appropriate degree of weakness for age, creatine kinase greater than 20 times the upper limit of normal, and genetic mutation known to be causative for Duchenne muscular dystrophy .~2. Appropriate degree of weakness for age, creatine kinase greater than 20 times the upper limit of normal and genetic or biopsy confirmation of Duchenne muscular dystrophy in a primary relative (e.g. brother or maternal uncle).~3. De-identified, genetic studies will be reviewed by collaborator Kevin Flanigan, MD prior to enrollment of subjects.~4. Age at entry: one month through 30 months.~Exclusion Criteria:~* Prior treatment with corticosteroids

- Gender: MALE
- Minimum Age: 1 Month
- Maximum Age: 30 Months
- Healthy Volunteers: f

Study Arms:
- Oral Prednisolone (Type: EXPERIMENTAL): Oral Prednisolone 5mg/kg/ day on two consecutive days, Friday and Saturday with breakfast

Based on this trial design, predict the completion outcome and termination type (if applicable).